UPDATE: UnitedHealth (UNH) Reaffirms FY12 Outlook into Investor Conference; Guides FY13 EPS Below Views
Get Alerts UNH Hot Sheet
Price: $493.86 +1.35%
Revenue Growth %: +8.6%
Financial Fact:
Total revenues: 46.29B
Today's EPS Names:
FRSB, DGICA, UXIN, More
Revenue Growth %: +8.6%
Financial Fact:
Total revenues: 46.29B
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
(Updated - November 26, 2012 6:15 AM EST)
UnitedHealth Group (NYSE: UNH) will host its annual Investor Conference with analysts and institutional investors in New York City on Tuesday, November 27, 2012, beginning at 8:00 a.m. EST. At the meeting, senior leaders will discuss the Company’s performance and outlook, including reviewing business trends and specific initiatives related to its various business units.
The Company will host an audio webcast of the presentation and management question and answer portions of this meeting and will make conference materials available on its Investors page at www.unitedhealthgroup.com. A replay of the conference will be available on the Company Web site through December 27, 2012.
In conjunction with the meeting, the Company will affirm its previous outlook for 2012 net earnings of $5.20 to $5.25 per share.
Management will discuss its 2013 financial outlook, which includes revenues of $123 billion to $124 billion and net earnings of $5.25 to $5.50 per share. The Street sees FY13 EPS of $5.58.
UnitedHealth Group (NYSE: UNH) will host its annual Investor Conference with analysts and institutional investors in New York City on Tuesday, November 27, 2012, beginning at 8:00 a.m. EST. At the meeting, senior leaders will discuss the Company’s performance and outlook, including reviewing business trends and specific initiatives related to its various business units.
The Company will host an audio webcast of the presentation and management question and answer portions of this meeting and will make conference materials available on its Investors page at www.unitedhealthgroup.com. A replay of the conference will be available on the Company Web site through December 27, 2012.
In conjunction with the meeting, the Company will affirm its previous outlook for 2012 net earnings of $5.20 to $5.25 per share.
Management will discuss its 2013 financial outlook, which includes revenues of $123 billion to $124 billion and net earnings of $5.25 to $5.50 per share. The Street sees FY13 EPS of $5.58.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- Allison Transmission (ALSN) Tops Q1 EPS by 2c, Beats on Revenue; Offers FY24 Revenue Guidance
- The Bancorp (TBBK) Reports In-Line Q1 EPS
Create E-mail Alert Related Categories
Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!